4.2.15. Morpholine enaminone of acetophenone (4h):
6.5 Hz, 2H), 1.64 (s, 3H), 1.61–1.56 (m, 2H), 1.45–1.42 (m, 2H),
ACCEPTED MANUSCRIPT
1.02 (s, 6H) 13C NMR (126 MHz, CDCl3): δ 198.7, 144.1, 139.3,
136.8, 131.0, 128.1, 127.7, 125.7, 122.8, 108.8, 100.5, 48.1, 42.4,
40.0, 35.2, 32.9, 28.7, 27.7, 24.2, 20.0, 19.7 IR (cm-1): 2923,
2863, 1665, 1583, 1300, 1262, 1111, 748, 703 ESI-HRMS (m/z)
[M+H]+ calc’d for C22H30NO+: 324.2322; found: 324.2346
The title compound was prepared according to the general
procedure with acetophenone (23 µL, 0.20 mmol, 1.0 equiv) and
morpholine Gold’s reagent (5g, 54 mg, 0.22 mmol, 1.1 equiv)
then heated at 65 ºC for 12 hours. The crude oil was purified by
flash column chromatography on silica gel (ethyl
acetate/hexanes= 60% to 80%) to yield the title compound (36.3
mg, 84%) as a brown oil. Rf: 0.13 (70% ethyl acetate/hexanes)
1H NMR (500 MHz, CDCl3): δ 7.88 (d, J = 7.5 Hz, 2H), 7.73 (d,
J = 12.6 Hz, 1H), 7.47–7.40 (m, 3H), 5.88 (d, J = 12.6 Hz, 1H),
3.76 (at, J = 4.8 Hz, 4H), 3.40 (at, J = 4.2 Hz, 4H) 13C NMR
(151 MHz, CDCl3): δ 189.3, 152.9, 140.3, 131.3, 128.3, 127.6,
92.6, 66.3 IR (cm-1): 2922, 2853, 1641, 1597, 1582, 1547, 1444,
1372, 1313, 1283, 1207, 1115, 1055, 1022, 927, 885, 760, 705,
4.2.19. Piperidine enaminone of geranylacetone (4l):
The title compound was prepared according to the general
procedure with geranylacetone (15 µL, 0.20 mmol, 1.0 equiv)
and piperidine Gold’s reagent (5f, 54 mg, 0.22 mmol, 1.1 equiv)
then heated at 65 ºC for 2 hours. The crude oil was purified by
flash column chromatography on silica gel (ethyl
acetate/hexanes= 40% to 60%) to yield the title compound (27.2
mg, 62%) as a yellow solid. Rf: 0.29 (60% ethyl acetate/hexanes)
1H NMR (500 MHz, CDCl3): δ 7.48 (d, J = 12.8 Hz, 1H), 5.14–
5.06 (m, 3H), 3.23 (brs, 4H), 2.34–2.28 (m, 4H), 2.07–2.02 (m,
3H), 1.97–1.94 (m, 1H), 1.67–1.58 (m, 15H) 13C NMR (126
MHz, CDCl3): δ 198.2, 151.3, 135.6, 131.4, 124.7, 124.5, 123.9,
39.8, 32.1, 26.9, 26.8, 25.8, 25.8, 24.5, 24.4, 24.2, 23.5, 17.8,
16.1. IR (cm-1): 2924, 2855, 2348, 2166, 1610, 1563, 1447, 1369,
1239, 1100, 1026, 983, 852, 765 ESI-HRMS (m/z): [M+H]+
calc’d for C19H32NO+: 290.2478; found: 290.2501
662 ESI-HRMS (m/z): [M+H]+ calc’d for C13H16NO2 :
218.1176; found: 218.1179
+
4.2.16. Indoline enaminone of acetophenone (4i):
The title compound was prepared according to the general
procedure with acetophenone (23 µL, 0.20 mmol, 1.0 equiv) and
indoline Gold’s reagent (5h, 69 mg, 0.22 mmol, 1.1 equiv) then
heated at 65 ºC for 12 hours. The crude oil was purified by flash
column chromatography on silica gel (ethyl acetate/hexanes=
60% to 80%) to yield the title compound (39.1 mg, 78%) as a
yellow solid. Rf: 0.19 (20% ethyl acetate/hexanes) 1H NMR (500
MHz, CDCl3): δ 8.41 (d, J = 12.4 Hz, 1H), 7.96 (d, J = 7.1 Hz,
1H), 7.51–7.43 (m, 3H), 7.20 (d, J = 7.7 Hz, 2H), 7.10 (d, J = 7.9
Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 6.04 (d, J = 12.6 Hz, 1H), 3.94
(t, J = 8.4 Hz, 2H), 3.26 (t, J = 8.4 Hz, 2H) 13C NMR (151 MHz,
CDCl3): δ 189.1, 143.9, 141.5, 140.0, 131.5, 131.2, 128.4, 128.1,
127.8, 125.7, 123.2, 109.2, 96.6, 48.3, 27.7 IR (cm-1): 2924,
1643, 1579, 1542, 1598, 1496, 1258, 1208, 1052, 883, 747, 703
ESI-HRMS (m/z): [M+H]+ calc’d for C17H16NO+: 250.1226;
found: 250.1221
4.2.20. Morpholine enaminone of γ-butyrolactone (4m):
The title compound was prepared according to the general
procedure with γ-butyrolactone (44 µL, 0.20 mmol, 1.0 equiv)
and morpholine Gold’s reagent (5g, 54 mg, 0.22 mmol, 1.1
equiv) then heated at 65 ºC for 6 hours. The crude oil was
purified by flash column chromatography on silica gel (ethyl
acetate/hexanes= 40% to 60%) to yield the title compound (36.4
mg, 74%) as
a
yellow solid.
Rf: 0.15 (90% ethyl
1
acetate/hexanes) H NMR (400 MHz, CDCl3): δ 7.11 (t, J = 2.0
Hz, 1H), 4.27 (t, J = 7.6 Hz, 2H), 3.72 (t, J = 4.4 Hz, 4H), 3.42 (t,
J = 4.4 Hz, 4H), 3.01 (dd, J = 8.0, 2.0 Hz, 2H) 13C NMR (151
MHz, CDCl3): δ 175.5, 145.2, 88.2, 66.6, 64.6, 49.8, 26.2 IR
(cm-1): 2922, 2855, 1723, 1622, 1445, 1363, 1270, 1230, 1158,
1114, 1021, 1003, 863, 747 ESI-HRMS (m/z): [M+H]+ calc’d
4.2.17. Osimertinib precursor (4j):
The title compound was prepared according to the general
procedure with N-Me-3-acetylindole25 (35 mg, 0.20 mmol, 1.0
equiv) and morpholine Gold’s reagent (5a, 36 mg, 0.22 mmol,
1.1 equiv) then heated at 65 ºC for 2 hours. The yellow oil was
washed with pentane (3 x 2 mL), the pentane layer was
discarded, and the oil was dried under vacuum (ca.100 mtorr) to
reveal the title compound as a yellow-orange foam (43.2 g, 94%).
+
for C9H14NO3 : 184.0968; found: 184.0980
4.2.21. Scalable synthesis of dimethyl enaminone of 2-butanone
(4m):
To a flame-dried 5-L round-bottomed flask equipped with a
magnetic stir bar was added solid LiO-t-Bu (88.1 g, 1.1 mol, 1.1
equiv). To the stirred solid, was added THF (2.0 L, 0.5 M) via
cannula, and this mixture was allowed to stir at room temperature
for 10 minutes to allow for complete dissolution of LiO-t-Bu
solid. 2-butanone (72.1 g, 1.0 mol, 1.0 equiv) was added
dropwise at room temperature to the reaction mixture over 15
minutes, resulting in a light yellow mixture. After stirring at
room temperature for 30 minutes, methyl Gold’s reagent (5a, 182
g, 1.1 mol, 1.1 equiv) was added in 5 portions over 30 minutes.
The reaction vessel was fitted with an oven-dried reflux
condenser and transferred to a heating mantle that was then
warmed to a gentle reflux.
1
Rf: 0.12 Ethyl acetate H NMR (400 MHz, CDCl3): δ 8.40–8.37
(m, 1H), 7.76 (d, J = 12.5 Hz, 1H), 7.67 (s, 1H), 7.33–7.25 (m,
3H), 5.64 (d, J = 12.5 Hz, 1H), 3.81 (s, 3H), 3.00 (brs, 6H) 13C
NMR (151 MHz, CDCl3): δ 184.9, 152.0, 137.5, 133.0, 126.9,
123.2, 122.7, 122.6, 122.2, 121.6, 118.3, 109.5, 94.1, 33.4 IR
(cm-1): 2919, 1635, 1574, 1549, 1523, 1466, 1369, 1331, 1225,
1081, 1048, 1011, 884, 791, 748, 574 ESI-HRMS (m/z): [M+H]+
calc’d for C14H17N2O+: 229.1335; found: 229.1336
4.2.18. Indoline enaminone of dihydro-β-ionone (4k):
The title compound was prepared according to the general
procedure with dihydro-β-ionone (42 µL, 0.20 mmol, 1.0 equiv)
and indoline Gold’s reagent (5h, 69 mg, 0.22 mmol, 1.1 equiv)
then heated at 65 ºC for 1.5 hours. The crude oil was purified by
flash column chromatography on silica gel (ethyl
acetate/hexanes= 10% to 30%) to yield the title compound (36.4
mg, 56%) as a yellow solid. Rf: 0.22 (20% ethyl acetate/hexanes)
1H NMR (500 MHz, CDCl3): δ 8.12 (d, J = 13.0 Hz, 1H), 7.18
(d, J = 7.5 Hz, 2H), 7.01 (d, J = 8.0 Hz, 1H), 6.94 (t, J = 7.4 Hz,
1H), 5.34 (d, J = 13.0 Hz, 1H), 3.82 (t, J = 8.5 Hz, 2H), 3.23 (t, J
= 8.5 Hz, 2H), 2.55–2.52 (m, 2H), 2.37–2.33 (m, 2H), 1.92 (t, J =
After stirring at reflux for 12 hours, the reaction apparatus was
removed from the heating mantle and allowed to cool to room
temperature. Once at room temperature, the reaction was diluted
with sat. aq. NH4Cl (2.5 L) and chloroform (3 L). The layers
were separated, and the aqueous layer was extracted with
chloroform (3 x 2 L). The combined organics were washed with
brine (5 mL), dried over anhydrous sodium sulfate, filtered, and
concentrated under reduced pressure by rotary evaporation to
give the crude enaminone as a black oil. The black oil was
purified by fractional distillation through a 5 cm vigreux column